Assessment of 4 Doses of SARS-CoV-2 Messenger RNA-Based Vaccine in Recipients of a Solid Organ Transplant.
Assessment of 4 Doses of SARS-CoV-2 Messenger RNA-Based Vaccine in Recipients of a Solid Organ Transplant.
复制标题
DOI：
10.1001/jamanetworkopen.2021.36030
复制
发表时间：
2021-11-01
影响因子：
13.8
通讯作者：
Izopet J
中科院分区：
文献类型：
--
作者：
Kamar N;Abravanel F;Marion O;Romieu-Mourez R;Couat C;Del Bello A;Izopet J
该病例系列研究评估了第四剂SARS-CoV-2信使RNA（mRNA）疫苗是否与法国实体器官移植受者的抗SARS-CoV-2抗体应答改善相关。
This case series study assesses whether a fourth dose of a SARS-CoV-2 messenger RNA (mRNA)–based vaccine is associated with improved anti–SARS-CoV-2 antibody response in solid organ transplant recipients in France.